Journal of Natural Products 2001-08-01

Investigation of the coupling reaction of tetraacetylsecologanin with oxotryptamine and its derivative.

A Patthy-Lukáts, G Beke, L F Szabó, B Podányi

Index: J. Nat. Prod. 64(8) , 1032-9, (2001)

Full Text: HTML

Abstract

The coupling reaction of tetraacetylsecologanin with 2,3-dihydro-2-oxotryptamine and its N(b)-benzyl derivative was investigated. With the benzylated amine, the reaction was stopped at the tetracyclic ester level, and with the unsubstituted amine it was immediately followed by lactamization. In both cases, the products were formed with high stereoselectivity at C-3, but as an epimeric pair of 7R and 7S in a ratio of 1:3. The bulky benzyl substituent at N-4 directed the stereoselectivity at C-3 in favor of the S configuration. In the nonbenzylated compounds, the reversible coupling reaction is probably nonstereoselective, but in lactamization the 3R epimer is sterically favored and faster and gives the final lactam in this configuration. The formation of the spiro compounds may serve as a model reaction in the interpretation of the stereoselectivity of the coupling reaction of secologanin with tryptamine in the presence of strictosidine synthase.


Related Compounds

  • Secologanin

Related Articles:

The leaf epidermome of Catharanthus roseus reveals its biochemical specialization.

2008-03-01

[Plant Cell 20(3) , 524-42, (2008)]

2,4-D and alkaloid accumulation in periwinkle cell suspensions.

1994-01-01

[Biochimie 76(5) , 410-6, (1994)]

Indole alkaloid biosynthesis in Catharanthus roseus: new enzyme activities and identification of cytochrome P450 CYP72A1 as secologanin synthase.

2000-12-01

[Plant J. 24 , 797, (2000)]

Strategies for engineering plant natural products: the iridoid-derived monoterpene indole alkaloids of Catharanthus roseus.

2012-01-01

[Meth. Enzymol. 515 , 189-206, (2012)]

Secologanin synthase which catalyzes the oxidative cleavage of loganin into secologanin is a cytochrome P450.

2000-01-01

[Phytochemistry 53(1) , 7-12, (2000)]

More Articles...